We are live on
!
Find out more
Lineage Cell Therapeutics
LCTX
LCTX
68 hedge funds and large institutions have $134M invested in Lineage Cell Therapeutics in 2015 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 25 increasing their positions, 10 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
150% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 10
36% more capital invested
Capital invested by funds: $98.5M → $134M (+$35.3M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4.8% less ownership
Funds ownership: 49.66% → 44.86% (-4.8%)
8% less funds holding
Funds holding: 74 → 68 (-6)
50% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 12
82% less call options, than puts
Call options by funds: $284K | Put options by funds: $1.55M
Holders
68
Holders Change
-6
Holders Change %
-8.11%
% of All Funds
1.78%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
6
Increased
25
Reduced
10
Closed
12
Calls
$284K
Puts
$1.55M
Net Calls
-$1.26M
Net Calls Change
-$867K
Top Buyers
Top Sellers
| 1 |
CCM
Consonance Capital Management
New York
|
-$1.62M |
| 2 |
Jane Street
New York
|
-$376K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$192K |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$132K |
| 5 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$102K |
